Senescence-associated T cells in immunosenescence and diseases
International Immunology · 04.02.2025 · 37 (3) · 143-152
DOI: 10.1093/intimm/dxae056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 25.09.2024. Verfasst von Yuji Fukushima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulation of Neurocognitive Disorders (Cyn-K Project), Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawahara-cho, Kyoto 6…. Hauptthemen laut MEDLINE: Immunosenescence, Aging, T-Lymphocytes, Cellular Senescence. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Astellas Pharma in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ono Pharmaceutical, Cyn-K Project.
Abstract (Originalsprache)
Age-related changes in the immune system, referred to as immunosenescence, appear to evolve with rather paradoxical manifestations, a diminished adaptive immune capacity, and an increased propensity for chronic inflammation often with autoimmunity, which may underlie the development of diverse disorders with age. Immunosenescent phenotypes are associated with the emergence of unique lymphocyte subpopulations of both T and B lineages. We report that a CD153+ programmed cell death protein 1 (PD-1)+ CD4+ T-cell subpopulation with severely attenuated T-cell receptor (TCR)-responsiveness, termed senescence-associated T (SAT) cells, co-evolve with potentially autoreactive CD30+ B cells, such as spontaneous germinal center B cells and age-associated B cells, in aging mice. SAT cells and CD30+ B cells are reciprocally activated with the aid of the interaction of CD153 with CD30 in trans and with the TCR complex in cis, resulting in the restoration of TCR-mediated proliferation and secretion of abundant pro-inflammatory cytokines in SAT cells and the activation and production of autoantibodies by CD30+ B cells. Besides normal aging, the development of SAT cells coupled with counterpart B cells may be robustly accelerated and accumulated in the relevant tissues of lymphoid or extra-lymphoid organs under chronic inflammatory conditions, including autoimmunity, and may contribute to the pathogenesis and aggravation of the disorders. This review summarizes and discusses recent advances in the understanding of SAT cells in the contexts of immunosenescent phenotypes, as well as autoimmune and chronic inflammatory diseases, and it provides a novel therapeutic clue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Regulation of Neurocognitive Disorders (Cyn-K Project), Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawahara-cho, Kyoto 606-8507, Japan.
- Medical Innovation Center, Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawahara-cho, Kyoto 606-8507, Japan.
- Laboratory of Tumor Tissue Response, Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawahara-cho, Kyoto 606-8507, Japan.
Förderung
- Astellas Pharma in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program
- Ono Pharmaceutical
- Cyn-K Project
- Japan Society for the Promotion of Science (JSPS) KAKENHI
- Takeda Science Foundation
Zitieren
APA
Fukushima, Y., Ueno, R., Minato, N., & Hattori, M. (2025). Senescence-associated T cells in immunosenescence and diseases. International Immunology, 37(3), 143-152. https://doi.org/10.1093/intimm/dxae056
Vancouver
Fukushima Y, Ueno R, Minato N, Hattori M. Senescence-associated T cells in immunosenescence and diseases. International Immunology. 2025;37(3):143-152. doi:10.1093/intimm/dxae056
BibTeX
@article{Fukushima2025,
author = {Fukushima, Yuji and Ueno, Ryuji and Minato, Nagahiro and Hattori, Masakazu},
title = {Senescence-associated T cells in immunosenescence and diseases},
journal = {International Immunology},
year = {2025},
volume = {37},
number = {3},
pages = {143--152},
doi = {10.1093/intimm/dxae056}
}
EUVIMED